{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:01:07Z","timestamp":1790395267539,"version":"4.1.0"},"reference-count":26,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,9,25]]},"DOI":"10.1253\/circj.cj-25-0709","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T22:09:02Z","timestamp":1776463742000},"page":"1412-1424","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Nuclear Factor-\u03baB1 With Andrographolide\u3000\u2015 Novel Strategy to Inhibit Vascular Lesions and Aneurysm Formation in Abdominal Aortic Aneurysm \u2015"],"prefix":"10.1253","volume":"90","author":[{"given":"Ying","family":"Wen","sequence":"first","affiliation":[{"name":"Institute of Pediatrics, Guangzhou Women and Children\u2019s Medical Centre, Guangzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Fu","sequence":"first","affiliation":[{"name":"Institute of Pediatrics, Guangzhou Women and Children\u2019s Medical Centre, Guangzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The Second Affiliated Hospital of Guangzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Pediatrics, Guangzhou Women and Children\u2019s Medical Centre, Guangzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixian","family":"Ren","sequence":"additional","affiliation":[{"name":"Institute of Occupational and Environmental Health, Guangzhou Medical University,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefeng","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The Second Affiliated Hospital of Guangzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Ho","family":"Tang","sequence":"additional","affiliation":[{"name":"Institute of Pediatrics, Guangzhou Women and Children\u2019s Medical Centre, Guangzhou Medical University"},{"name":"Heart Center, The Third Affiliated Hospital of Zhengzhou University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Golledge J, Thanigaimani S, Powell JT, Tsao PS. Pathogenesis and management of abdominal aortic aneurysm.: <i>Eur Heart J<\/i> 2023; 44: 2682\u20132697, doi:10.1093\/eurheartj\/ehad386.","DOI":"10.1093\/eurheartj\/ehad386"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Ogino H, Iida O, Akutsu K, Chiba Y, Hayashi H, Ishibashi-Ueda H, et al. JCS\/JSCVS\/JATS\/JSVS 2020 Guideline on diagnosis and treatment of aortic aneurysm and aortic dissection. <i>Circ J<\/i> 2023; 87: 1410\u20131621, doi:10.1253\/circj.CJ-22-0794.","DOI":"10.1253\/circj.CJ-22-0794"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Gao J, Cao H, Hu G, Wu Y, Xu Y, Cui H, et al. The mechanism and therapy of aortic aneurysms. <i>Signal Transduct Target Ther<\/i> 2023; 8: 55, doi:10.1038\/s41392-023-01325-7.","DOI":"10.1038\/s41392-023-01325-7"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Ailawadi G, Moehle CW, Pei H, Walton SP, Yang Z, Kron IL, et al. Smooth muscle phenotypic modulation is an early event in aortic aneurysms. <i>J Thorac Cardiovasc Surg<\/i> 2009; 138: 1392\u20131399, doi:10.1016\/j.jtcvs.2009.07.075.","DOI":"10.1016\/j.jtcvs.2009.07.075"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Chen J, Hu L, Liu Z. Medical treatments for abdominal aortic aneurysm: An overview of clinical trials. <i>Expert Opin Investig Drugs<\/i> 2024; 33: 979\u2013992, doi:10.1080\/13543784.2024.2377747.","DOI":"10.1080\/13543784.2024.2377747"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Qian G, Adeyanju O, Olajuyin A, Guo X. Abdominal aortic aneurysm formation with a focus on vascular smooth muscle cells. <i>Life<\/i> 2022; 12: 191, doi:103390\/life12020191.","DOI":"10.3390\/life12020191"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Zhang H, Li S, Si Y, Xu H. Andrographolide and its derivatives: Current achievements and future perspectives. <i>Eur J Med Chem<\/i> 2021; 224: 113710, doi:10.1016\/j.ejmech.2021.113710.","DOI":"10.1016\/j.ejmech.2021.113710"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Nguyen VS, Loh XY, Wijaya H, Wang J, Lin Q, Lam Y, et al. Specificity and inhibitory mechanism of andrographolide and its analogues as antiasthma agents on NF-\u03baB p50. <i>J Nat Prod<\/i> 2015; 78: 208\u2013217, doi:10.1021\/np5007179.","DOI":"10.1021\/np5007179"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Wu T, Peng Y, Yan S, Li N, Chen Y, Lan T. Andrographolide ameliorates atherosclerosis by suppressing pro-inflammation and ROS generation-mediated foam cell formation. <i>Inflammation<\/i> 2018; 41: 1681\u20131689, doi:10.1007\/s10753-018-0812-9.","DOI":"10.1007\/s10753-018-0812-9"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Ren J, Liu Z, Wang Q, Giles J, Greenberg J, Sheibani N, et al. Andrographolide ameliorates abdominal aortic aneurysm progression by inhibiting inflammatory cell infiltration through downregulation of cytokine and integrin expression. <i>J Pharmacol Exp Ther<\/i> 2016; 356: 137\u2013147, doi:10.1124\/jpet.115.227934.","DOI":"10.1124\/jpet.115.227934"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Wen Y, Liu Y, Li Q, Tan J, Fu X, Liang Y, et al. Spatiotemporal ATF3 expression determines VSMC fate in abdominal aortic aneurysm. <i>Circ Res<\/i> 2024; 134: 1495\u20131511, doi:10.1161\/CIRCRESAHA.124.324323.","DOI":"10.1161\/CIRCRESAHA.124.324323"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Cartwright T, Perkins ND, Wilson CL. NFKB1: A suppressor of inflammation, ageing and cancer. <i>FEBS J<\/i> 2016; 283: 1812\u20131822, doi:10.1111\/febs.13627.","DOI":"10.1111\/febs.13627"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Li X, Yuan W, Wu J, Zhen J, Sun Q, Yu M. Andrographolide, a natural anti-inflammatory agent: An update. <i>Front Pharmacol<\/i> 2022; 13: 920435, doi:10.3389\/fphar.2022.920435.","DOI":"10.3389\/fphar.2022.920435"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Gou T, Hu M, Xu M, Chen Y, Chen R, Zhou T, et al. Novel wine in an old bottle: Preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases. <i>J Pharm Anal<\/i> 2023; 13: 563\u2013589, doi:10.1016\/j.jpha.2023.05.010.","DOI":"10.1016\/j.jpha.2023.05.010"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Quintana RA, Taylor WR. Cellular mechanisms of aortic aneurysm formation. <i>Circ Res<\/i> 2019; 124: 607\u2013618, doi:10.1161\/CIRCRESAHA.118.313187.","DOI":"10.1161\/CIRCRESAHA.118.313187"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Adachi Y, Morita H. Single-cell analysis as a reductionist approach to deep knowledge of pathogenesis and pathophysiology of abdominal aortic aneurysm. <i>Circ J<\/i> 2025; 89: 1871\u20131873, doi:10.1253\/circj.CJ-25-0140.","DOI":"10.1253\/circj.CJ-25-0140"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Lamb FS, Choi H, Miller MR, Stark RJ. TNF\u03b1 and reactive oxygen signaling in vascular smooth muscle cells in hypertension and atherosclerosis. <i>Am J Hypertens<\/i> 2020; 33: 902\u2013913, doi:10.1093\/ajh\/hpaa089.","DOI":"10.1093\/ajh\/hpaa089"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Tang HY, Chen AQ, Zhang H, Gao XF, Kong XQ, Zhang JJ. Vascular smooth muscle cells phenotypic switching in cardiovascular diseases. <i>Cells<\/i> 2022; 11: 4060, doi:10.3390\/cells11244060.","DOI":"10.3390\/cells11244060"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Golledge J. Abdominal aortic aneurysm: Update on pathogenesis and medical treatments. <i>Nat Rev Cardiol<\/i> 2018; 16: 225\u2013242, doi:10.1038\/s41569-018-0114-9.","DOI":"10.1038\/s41569-018-0114-9"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Yang H, Zhou T, Stranz A, DeRoo E, Liu B. Single-cell RNA sequencing reveals heterogeneity of vascular cells in early stage murine abdominal aortic aneurysm: Brief report. <i>Arterioscler Thromb Vasc Biol<\/i> 2021; 41: 1158\u20131166, doi:10.1161\/atvbaha.120.315607.","DOI":"10.1161\/ATVBAHA.120.315607"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Shi S, Ji X, Shi J, Shi S, She F, Zhang Q, et al. Andrographolide in atherosclerosis: Integrating network pharmacology and in vitro pharmacological evaluation. <i>Biosci Rep<\/i> 2022; 42: BSR20212812, doi:10.1042\/BSR20212812.","DOI":"10.1042\/BSR20212812"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Li X, Yuan K, Zhu Q, Lu Q, Jiang H, Zhu M, et al. Andrographolide ameliorates rheumatoid arthritis by regulating the apoptosis-NETosis balance of neutrophils. <i>Int J Mol Sci<\/i> 2019; 20: 5035, doi:10.3390\/ijms20205035.","DOI":"10.3390\/ijms20205035"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Zhai ZJ, Li HW, Liu GW, Qu XH, Tian B, Yan W, et al. Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo. <i>Br J Pharmacol<\/i> 2014; 171: 663\u2013675, doi:10.1111\/bph.12463.","DOI":"10.1111\/bph.12463"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Chao CY, Lii CK, Tsai IT, Li CC, Liu KL, Tsai CW, et al. Andrographolide inhibits ICAM-1 expression and NF-\u03baB activation in TNF-\u03b1-treated EA.hy926 cells. <i>J Agric Food Chem<\/i> 2011; 59: 5263\u20135271, doi:10.1021\/jf104003y.","DOI":"10.1021\/jf104003y"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Guo Q, Li J, Wang Z, Wu X, Jin Z, Zhu S, et al. Potassium dehydroandrographolide succinate regulates the MyD88\/CDH13 signaling pathway to enhance vascular injury-induced pathological vascular remodeling. <i>Chin J Nat Med<\/i> 2024; 22: 62\u201374, doi:10.1016\/S1875-5364(24)60562-5.","DOI":"10.1016\/S1875-5364(24)60562-5"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Nie X, Shen C, Tan J, Yang X, Wang W, Dai Y, et al. Andrographolide attenuates established pulmonary hypertension via rescue of vascular remodeling. <i>Biomolecules<\/i> 2021; 11: 1801, doi:10.3390\/biom11121801.","DOI":"10.3390\/biom11121801"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/10\/90_CJ-25-0709\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:27:35Z","timestamp":1790393255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/10\/90_CJ-25-0709\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-25-0709","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"CJ-25-0709"}}